betamethasone

(redirected from Betamethasone dipropionate)
Also found in: Dictionary, Medical.

betamethasone

[¦bād·ə′meth·ə‚zōn]
(pharmacology)
A white, crystalline powder with a melting point of 240°C; a corticosteroid hormone.
Mentioned in ?
References in periodicals archive ?
Antipsoriatic effect of a novel aerosol foam formulation of the fixed combination calcipotriene plus betamethasone dipropionate in patients with psoriasis, using a modified psoriasis plaque test.
An ointment formulation containing both the vitamin D analogue calcipotriene and betamethasone dipropionate is proving more effective than either drug alone, but is approved only in Canada and Europe.
Some therapies including Ustekinumab, Adalimumab, and Calcipotriene / betamethasone dipropionate will observe rapid growth in their sales during the forecast period.
LEO Pharma announces it has submitted a New Drug Application (NDA) for calcipotriene and betamethasone dipropionate aerosol foam, 0.
030-2014 calcipotriol / betamethasone dipropionate gel 0.
Contract awarded for calcipotriol / betamethasone dipropionate, gel 0.
LONDON, August 10 /PRNewswire/ -- A routinely prescribed ointment applied once a day, which is a combination of two existing treatments for psoriasis - calciptriol and betamethasone dipropionate - is more effective in the severe form of the condition than some recently NICE-approved biological treatments, according to a new study published this month in the leading skin journal the International Journal of Dermatology.
Contract awarded for code: 2045 calcipotriol / betamethasone dipropionate, gel 0.
In anticipation of commencement of human proof-of-concept clinical trials, Apricus Bio has conducted extensive pre-clinical and long-term stability studies on PsoriaVa(TM), a NexACT-based formulation of calcipotriene and betamethasone dipropionate for the treatment of psoriasis.
Contract awarded for code igss calcipotriol 2,045 / betamethasone dipropionate gel 0.
Food and Drug Administration ("FDA") for its Abbreviated New Drug Application for Betamethasone Dipropionate Lotion (Augmented) USP, 0.
Two of the approvals are for topical products used in dermatology: clotrimazole and betamethasone dipropionate lotion (bioequivalent to Schering-Plough's Lotrisone(R) lotion) and alclometasone dipropionate ointment (bioequivalent to GlaxoSmithKline's Aclovate(R) ointment).